Laddar...
Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal Adenocarcinoma
Pancreatic cancer costs nearly 40,000 lives in the U.S. each year and has one of the lowest survival rates among cancers. Effective treatment of pancreatic ductal adenocarcinoma is hindered by lack of a reliable biomarker. To address this challenge, aptamers were selected by cell-SELEX (Systematic E...
Sparad:
| I publikationen: | Sci Rep |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4658478/ https://ncbi.nlm.nih.gov/pubmed/26603187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep16788 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|